Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed …

SA Halperin, S McNeil, J Langley, M Blatter, M Dionne… - Vaccine, 2011 - Elsevier
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine is not …

Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose

SA Halperin, D Scheifele, G De Serres, F Noya… - Vaccine, 2012 - Elsevier
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine during …

Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in …

NP Klein, J Hansen, E Lewis, L Lyon… - The Pediatric …, 2010 - journals.lww.com
Background: Prelicensure clinical studies may not include sufficient numbers of subjects to
assess the potential for rare postvaccination adverse events. The aim of this postlicensure …

Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after …

M Kovac, L Kostanyan, N Mesaros… - Human Vaccines & …, 2018 - Taylor & Francis
Pertussis is a highly contagious disease, for which periodic peaks in incidence and an
increasing number of outbreaks have been observed over the last decades. The reduced …

[HTML][HTML] Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular …

V Pool, A Tomovici, DR Johnson, DP Greenberg… - Vaccine, 2018 - Elsevier
Background In a prospective, randomized pivotal phase III clinical trial, the immunogenicity
and reactogenicity of a tetanus-diphtheria-acellular pertussis vaccine (Tdap) and a tetanus …

Randomized controlled trial of the safety and immunogenicity of revaccination with tetanus-diphtheria-acellular pertussis vaccine (Tdap) in adults 10 years after a …

SA Halperin, C Donovan, GS Marshall… - Journal of the …, 2019 - academic.oup.com
Background Reduced-antigen-content tetanus, diphtheria, and acellular pertussis (Tdap)
vaccine is recommended in many countries for boosting immunity in adolescents and adults …

[HTML][HTML] Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular …

A Tomovici, L Barreto, P Zickler, W Meekison, F Noya… - Vaccine, 2012 - Elsevier
Persistence of antibodies after a single dose of Tdap vaccine (tetanus, diphtheria, and 5-
component acellular pertussis vaccine) was evaluated in a follow-up study of adolescents …

How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?

SA Halperin, L Sweet, D Baxendale… - The Pediatric …, 2006 - journals.lww.com
Background: Adult formulation tetanus and diphtheria toxoids and acellular pertussis
vaccines (Tdap) have been developed to prevent pertussis in adolescents and adults. There …

An adolescent–adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less …

JM Langley, G Predy, R Guasparini, B Law… - Vaccine, 2007 - Elsevier
In Canada, the fifth dose of the routine childhood immunization schedule against diphtheria,
tetanus, pertussis and polio is given at 4–6 years of age. Up to 30% of children may have …

[HTML][HTML] Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines …

KR Broder, MM Cortese, JK Iskander, K Kretsinger… - MMWR Recomm …, 2006 - cdc.gov
During spring 2005, two tetanus toxoid, reduced diphtheria toxoid and acellular pertussis
vaccine (Tdap) products formulated for use in adolescents (and, for one product, use in …